Literature DB >> 10790891

Expression of nerve growth factor-induced type 1 plasminogen activator inhibitor (PAI-1) mRNA is inhibited by genistein and wortmannin.

H Takahashi1, S Uno, Y Watanabe, K Arakawa, S Nakagawa.   

Abstract

Nerve growth factor (NGF), which acts as a neurotrophic factor in a rat pheochromocytoma cell line (PC12), stimulated type 1 plasminogen activator inhibitor (PAI-1) mRNA expression from 1 to 5 h, after addition at 5 ng/ml. PAI-1 antigen in culture medium, which was measured using an enzyme linked immunosorbent assay (ELISA), was also increased dose dependently by the addition of NGF. Neither epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), phorbol myristate acetate (PMA) nor forskolin increased PAI-1 mRNA expression in PC12 cells. Genistein, an inhibitor of tyrosine protein kinase, completely inhibited NGF induced PAI-1 mRNA in the presence of 100 microM. Wortmannin, a potent and specific inhibitor of phosphatidylinositol 3-kinase (PI-3 kinase), decreased induction of PAI-1 mRNA level at doses of > or = 10(-7) M.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790891     DOI: 10.1097/00001756-200004070-00040

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

2.  Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.

Authors:  Brandi R Whitley; Lea M Beaulieu; Jennifer C Carter; Frank C Church
Journal:  Gynecol Oncol       Date:  2006-10-30       Impact factor: 5.482

3.  Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.

Authors:  Maria U Rømer; Lise Larsen; Hanne Offenberg; Nils Brünner; Ulrik A Lademann
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

4.  Plasminogen enhances neuritogenesis on laminin-1.

Authors:  Ana Gutiérrez-Fernández; Neill A Gingles; Hongdong Bai; Francis J Castellino; Robert J Parmer; Lindsey A Miles
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

5.  NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.

Authors:  Georgios C Stefos; Ulf Soppa; Mara Dierssen; Walter Becker
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 6.  Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets.

Authors:  Ralf-Peter Czekay; Dong-Joo Cheon; Rohan Samarakoon; Stacie M Kutz; Paul J Higgins
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

Review 7.  Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

Authors:  Marzena Wyganowska-Świątkowska; Maja Matthews-Kozanecka; Teresa Matthews-Brzozowska; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.